For patients on mineralocorticoids, which finding would prompt immediate action?

In patients on mineralocorticoids, hypertension is a significant finding that prompts immediate action. Mineralocorticoids, such as aldosterone or synthetic variants like fludrocortisone, are known for their role in sodium retention, which can lead to an increase in blood volume and consequently result in elevated blood pressure.

When blood pressure rises excessively, it poses risks of serious cardiovascular complications, including stroke and heart attack. It is crucial to monitor blood pressure in patients receiving mineralocorticoids, as uncontrolled hypertension may necessitate adjustment of therapy or initiation of antihypertensive medications to mitigate these risks.

In contrast, hypotension, bradycardia, or hyperthermia, while potentially concerning, are not as directly connected to the effects of mineralocorticoids and may not require the same level of immediate intervention as hypertension does.